9.32
price up icon0.87%   0.08
after-market Handel nachbörslich: 9.46 0.14 +1.50%
loading
Schlusskurs vom Vortag:
$9.24
Offen:
$9.27
24-Stunden-Volumen:
22,770
Relative Volume:
0.54
Marktkapitalisierung:
$149.09M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-33.82M
KGV:
-0.3642
EPS:
-25.5891
Netto-Cashflow:
$-66.04M
1W Leistung:
+1.41%
1M Leistung:
+15.78%
6M Leistung:
+24.77%
1J Leistung:
+99.15%
1-Tages-Spanne:
Value
$9.1399
$9.49
1-Wochen-Bereich:
Value
$8.58
$9.75
52-Wochen-Spanne:
Value
$3.70
$9.99

Elicio Therapeutics Inc Stock (ELTX) Company Profile

Name
Firmenname
Elicio Therapeutics Inc
Name
Telefon
(857) 209-0050
Name
Adresse
451 D STREET, 5TH FLOOR, BOSTON
Name
Mitarbeiter
26
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
ELTX's Discussions on Twitter

Vergleichen Sie ELTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ELTX
Elicio Therapeutics Inc
9.32 147.01M 0 -33.82M -66.04M -25.59
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Elicio Therapeutics Inc Aktie (ELTX) Neueste Nachrichten

pulisher
Jul 22, 2025

What analysts say about Elicio Therapeutics Inc. stockConsistent high-performance stocks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

When the Price of (ELTX) Talks, People Listen - news.stocktradersdaily.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Elicio Therapeutics Inc. a good long term investmentExponential wealth increase - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How Elicio Therapeutics Inc. stock performs during market volatilityWeekly Double Return List - Newser

Jul 22, 2025
pulisher
Jul 20, 2025

What drives Elicio Therapeutics Inc. stock priceExplosive trading opportunities - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 19, 2025

Elicio Therapeutics Inc. Stock Analysis and ForecastDouble-digit growth - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 17, 2025

Elicio Therapeutics: Promising Trial Results and Commercial Potential Drive Buy Rating - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

H.C. Wainwright raises Elicio Therapeutics stock price target to $13 on trial outlook By Investing.com - Investing.com South Africa

Jul 17, 2025
pulisher
Jul 17, 2025

H.C. Wainwright raises Elicio Therapeutics stock price target to $13 on trial outlook - Investing.com Australia

Jul 17, 2025
pulisher
Jul 17, 2025

Elicio Therapeutics: HC Wainwright Raises PT to $13, Maintains Buy Rating - AInvest

Jul 17, 2025
pulisher
Jul 15, 2025

What makes Elicio Therapeutics Inc. stock price move sharplyFree Signals Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Elicio Therapeutics Inc. stock attracts strong analyst attentionTop Performer Shortlist - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Trend Tracker for (ELTX) - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 08, 2025

Elicio Therapeutics, Inc.'s (NASDAQ:ELTX) market cap up US$12m last week, benefiting both retail investors who own 47% as well as insiders - simplywall.st

Jul 08, 2025
pulisher
Jul 01, 2025

When (ELTX) Moves Investors should Listen - news.stocktradersdaily.com

Jul 01, 2025
pulisher
Jun 30, 2025

Elicio Therapeutics, Inc.(NasdaqCM: ELTX) dropped from Russell 3000E Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 26, 2025

JonesTrading Remains a Buy on Elicio Therapeutics (ELTX) - The Globe and Mail

Jun 26, 2025
pulisher
Jun 25, 2025

Is Elicio Therapeutics, Inc. overvalued or undervalued? - MarketsMojo

Jun 25, 2025
pulisher
Jun 18, 2025

Elicio Therapeutics Secures Strategic Financing As Pivotal Cancer Trial Data Approaches - Barchart.com

Jun 18, 2025
pulisher
Jun 17, 2025

Elicio Therapeutics to Host Virtual KOL Event on June 25, - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

Elicio Therapeutics to Host Virtual KOL Event on June 25, 2025 to Discuss AMP-Powered ELI-002 for the Treatment of KRAS mutation-driven Pancreatic Cancer - GlobeNewswire Inc.

Jun 17, 2025
pulisher
Jun 04, 2025

Elicio secures $10 million to extend cash runway By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

Elicio Therapeutics Secures $10 Million in Financing - citybiz

Jun 04, 2025
pulisher
Jun 04, 2025

Elicio Therapeutics Gets $10 Million Note Financing - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Elicio secures $10 million to extend cash runway - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Elicio Therapeutics Secures $10M Financing for Operations - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Elicio Therapeutics (ELTX) Secures $10M Financing to Extend Operations | ELTX Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Elicio Therapeutics Lands $10M Funding to Advance Revolutionary Cancer Vaccine Through Critical Trial Phase - Stock Titan

Jun 04, 2025
pulisher
May 20, 2025

Elicio Therapeutics announces board election results By Investing.com - Investing.com Nigeria

May 20, 2025
pulisher
May 20, 2025

Elicio Therapeutics Elects New Directors at Annual Meeting - TipRanks

May 20, 2025
pulisher
May 20, 2025

Elicio Therapeutics announces board election results - Investing.com

May 20, 2025
pulisher
May 14, 2025

Elicio Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025
pulisher
May 14, 2025

Elicio's (ELTX) ELI-002 Interim Analysis Anticipated in Phase 2 Trial | ELTX Stock News - GuruFocus

May 14, 2025
pulisher
May 13, 2025

Elicio Therapeutics: Q1 Earnings Snapshot - CTPost

May 13, 2025
pulisher
May 13, 2025

Elicio Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewswire

May 13, 2025
pulisher
May 08, 2025

Learn to Evaluate (ELTX) using the Charts - news.stocktradersdaily.com

May 08, 2025

Finanzdaten der Elicio Therapeutics Inc-Aktie (ELTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):